Jacques Bougie named Chairman of the Board of Directors

June 05, 2014  |   Blog   |    

MONTREAL, June 5, 2014 – Atrium Innovations Inc. (“Atrium” or the “Company”), a globally recognized leader in the development, manufacturing and commercialization of innovative, science-based natural health products, announced today that Jacques Bougie, former President and CEO of Alcan Inc., will serve as Chairman of the Board of Directors and be based in Montreal, Québec.

On behalf of Atrium’s owners – the Permira Funds, Fonds de solidarité FTQ and Caisse de dépôt et placement du Québec – John Coyle, Partner at Permira, said, “On behalf of the Board of Directors, we would like to welcome our new Board members. Jacques has an outstanding leadership track record along with significant operational and international experience, and we are confident that both he and Brian will provide unique insights and value to our Board in the years ahead.”

Mr. Bougie was the President and CEO of Alcan Inc., a Québec-based global aluminium producer and packaging products supplier, from 1993 to 2001.  In this role, he spearheaded the greatest expansion in the company’s history through its acquisition of AluSuisse in 2000 and laid the groundwork for the acquisition of the French group Péchiney in 2004.  Before serving as CEO, he was President and COO of Alcan from 1989 to 1993.  Over the past 25 years, Mr. Bougie has served on the boards of Royal Bank of Canada, Bell Canada, BCE Mobile Communications, Nova Chemicals, Rona, Novelis, and AbitibiBowater and currently sits on the boards of McCain Foods, CSL Group and SNC-Lavalin Group.  He currently chairs the Advisory Board of the Montréal Neurological Institute and Hospital and serves on the Board of Directors of a number of foundations.